David R. McAvoy - May 5, 2022 Form 4 Insider Report for Brickell Biotech, Inc. (FRTX)

Role
General Counsel and CCO
Signature
/s/ Christine G. Long, Attorney-in-Fact for David R. McAvoy (power of attorney previously filed)
Stock symbol
FRTX
Transactions as of
May 5, 2022
Transactions value $
$0
Form type
4
Date filed
5/9/2022, 04:17 PM
Previous filing
Jul 27, 2021
Next filing
Jan 26, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FRTX Stock Option (right to buy) Award $0 +300K $0.00 300K May 5, 2022 Common Stock 300K $0.26 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock options will vest 25% on the first anniversary of the grant date, and the remainder will vest in equal monthly installments over the following three years.